[O13] Oral Session 13"Cancer 2"

[O13-5] Retroviral replicating vector-mediated prodrug activator gene therapy and anti-PD-1 antibody combination therapy in a murine pancreatic cancer model

^○Hiroki Niwa^1,2, Toru Nakamura¹, Hiroki Kushiya¹, Tomohiro Suzuki¹, Kazuho Inoko¹, Kei Hiraoka^1,2, Akihito Inagaki³, Takahiro Tsuchikawa¹, Toshiaki Shichinohe¹, Noriyuki Kasahara^3,4, Satoshi Hirano¹ (1.Department of Gastroenterological Surgery II, Hokkaido University Graduate School of Medicine, 2.Department of Clinical Research, National Hospital Organization (NHO) Hakodate National Hospital, 3.Departments of Neurological Surgery, University of California, San Francisco (UCSF), 4.Departments of Radiation Oncology, University of California, San Francisco (UCSF))